ALK and non-small cell lung carcinoma: During this study, we screened 187 ALK-positive metastatic NSCLC patients and identified 27 patients with SBM, the synchronous brain metastasis frequency of patients with in ALK-rearranged non-small cell lung cancer is 14.4%.